Märkte und Analysen

Lonza and the next wave of healthcare solutions

May 5, 2026

Lesezeit: 3:57 mins

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

Key points:

Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
The company has high customer retention which creates resilient revenues.
It is investing heavily to support growth, including building manufacturing capacity in the US.
Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.

3305309 Exp: 7 august 2026

Chart of the Week | Makroökonomisch

Resilient through uncertainty

U.S. policy uncertainty has remained elevated and consumer sentiment has weakened. Even so, the economy has stayed resilient, and because growth has held up better than sentiment and headlines suggest, we continue to forecast 2% U.S. growth in 2026, in line with trend.

Artikel | Makroökonomisch

Fiscal dominance, inflation and the future of portfolio construction

The rules of the market may have changed. How should multi-asset investors respond?

IFMH | Aktien

Where’s the long-term value in AI?

AI investment enthusiasm is rising, but returns will vary widely. Long-term value is more likely where practical, commercially viable use cases are already beginning to emerge, says Walter Scott’s George Dent.

Chart of the Week | Makroökonomisch

Getting real in retail

Despite persistent concerns that sticky inflation would erode purchasing power and drag consumer spending lower, the May retail sales data tells a different story. Spending is up not just in dollar terms, but in quantity, highlighting continued consumer resilience.